equitysell

SOFR

Trust-weighted public proof page for SOFR. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
91 / 100
Current score
-1.60
Thesis calls
2
Active decisions
2

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

Beam Therapeutics Inc.sec_filingsopen

The provided excerpt of Beam Therapeutics’ (BEAM) 10-Q for the quarter ended 2026-03-31 contains only the cover page/filing compliance information (issuer details, exchange listing, checkboxes for filing status). It does not include financial statements, MD&A, cash runway, guidance, pipeline updates, risk factors, or any quantitative/disclosive items that would support a tradable view.

Mentioned: May 7, 2026, 7:22 AM EDTConviction: 80 / 100
Source: BEAM 10-Q report for 2026-03-31
EOG RESOURCES INCsec_filingsopen

The provided excerpt is only the cover page/header of EOG Resources, Inc.’s Form 10-Q for the quarter ended 2026-03-31. It contains listing, filing status, and registrant identification details but no financial results, guidance, production metrics, capital return, risks, or MD&A content. As-is, it does not support a directional investment thesis beyond confirming a routine filing.

Mentioned: May 5, 2026, 4:25 PM EDTConviction: 80 / 100
Source: EOG 10-Q report for 2026-03-31

Current stance

Recommendationsell
Authors2
Active decisions2
Latest pricen/a

Investment decisions

SOFR
risk_review

SOFR
risk_review

Unlock full asset monitoring

Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.